Metropolitan Life Insurance Company (MetLife)’s Dynatrace DT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,549
Closed -$757K 2370
2021
Q4
$757K Sell
12,549
-95
-0.8% -$6.47K 0.01% 1148
2021
Q3
$897K Buy
12,644
+435
+4% +$28.5K 0.01% 1046
2021
Q2
$713K Sell
12,209
-1,087
-8% -$56.8K 0.01% 1269
2021
Q1
$641K Sell
13,296
-598
-4% -$29K 0.01% 1262
2020
Q4
$601K Sell
13,894
-271
-2% -$10.8K 0.01% 1245
2020
Q3
$581K Buy
14,165
+2,101
+17% +$86K 0.01% 1106
2020
Q2
$490K Buy
12,064
+4,060
+51% +$134K 0.01% 1215
2020
Q1
$191K Buy
8,004
+3,945
+97% +$114K ﹤0.01% 1612
2019
Q4
$103K Buy
4,059
+1,712
+73% +$37.6K ﹤0.01% 2316
2019
Q3
$43.8K Buy
+2,347
New +$53.2K ﹤0.01% 2509

Other funds holding DT

Metropolitan Life Insurance Company (MetLife)'s DT Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Dynatrace (DT) in Q1 2022, closing a stake of 12,549 shares — an estimated $757K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DT in Q3 2019 and held it in 10 quarters. The position peaked at $897K in Q3 2021. 382 funds tracked by Wall St. Rank hold DT as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Dynatrace position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 12,549 Dynatrace shares in Q1 2022, an estimated $757K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Dynatrace in Q3 2019 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Dynatrace position peaked at $897K in Q3 2021.
  • 382 funds tracked by Wall St. Rank held Dynatrace as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.